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Abstract
How can scientometric mapping function as a tool of ’strategic intelligence’ to aid the gov-
ernance of emerging technologies? The present paper aims to address this question by
focusing on a set of recently developed scientometric techniques, namely overlay mapping.
We examine the potential these techniques have to inform, in a timely manner, analysts and
decision-makers about relevant dynamics of technical emergence. We investigate the capa-
bility of overlay mapping in generating informed perspectives about emergence across three
spaces: geographical, social, and cognitive. Our analysis relies on three empirical studies of
emerging technologies in the biomedical domain: RNA interference (RNAi), Human Papil-
loma Virus (HPV) testing technologies for cervical cancer, and Thiopurine Methyltransferase
(TPMT) genetic testing. The case-studies are analysed and mapped longitudinally by us-
ing publication and patent data. Results show the variety of ’intelligence’ inputs overlay
mapping can produce for the governance of emerging technologies. Overlay mapping also
confers to the investigation of emergence flexibility and granularity in terms of adaptability
to diﬀerent sources of data and selection of the levels of the analysis, respectively. These
features make possible the integration and comparison of results from diﬀerent contexts and
cases, thus providing possibilities for a potentially more ’distributed’ strategic intelligence.
The generated perspectives allow triangulation of findings, which is important given the
complexity featuring in technical emergence and the limitations associated with the use of
single scientometric approaches.
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1 Introduction
Emerging technologies have the potential to exert a long-term influence on a wide range of
domains of the socio-economic system by transforming existing industries or creating new ones
as well as changing knowledge production processes and related technical regimes (e.g. Corrocher
et al., 2003; Cozzens et al., 2010; Day and Schoemaker, 2000; Martin, 1995). The emergence of
novel technologies is not only associated with societal benefits, but also with unexpected adverse
and destabilising changes (Collingridge, 1980). The governance of emerging technologies has
therefore assumed an increasing relevance becoming priorities and part of the research agendas
of many national governments (Hilgartner and Lewenstein, 2014).
Developing policies to stimulate emergence as well as to reduce the lack of control and risk
of the unintended eﬀects of emerging technologies on the socio-economic system is however a
diﬃcult activity. Uncertainties, ambiguity, and rapid dynamics feature in the emergence process
of which directionality is the result of a variety of factors such as visions, goals, and expectations
of the actors involved (e.g. Geels, 2002; Stirling and Scoones, 2009; Van Lente and Rip, 1998).
Emergence in complex social systems as science and technology is reflective, i.e. actors are
at the same time regulated by and regulating the emergence process (de Haan, 2006). The
governance assumes an emergent character resulting from the complex interactions of these
actors whereby the explicit attempts to shape arrangements are only one part of this process
(e.g. Kooiman, 1993; Verbong and Geels, 2007). Governance is the result of both by intentional
and un-intentional influences, de facto including factors and actors non directly or purposefully
aiming at governing (Rip and Van Amerom, 2010). Lock-in and irreversibilities (David, 1985)
and risk of technological alternative to be crowed out (Martin, 1995) add to this complexity.
The governing of emerging technologies therefore requires tools of ’strategic intelligence’, i.e.
tools that are able to provide ’intelligence’ inputs to the policy-making process for the develop-
ment of governance capable to cope with the uncertain, ambiguous, and rapid evolvements of
technical emergence (Guston and Sarewitz, 2002; Kuhlmann et al., 1999). Conventional tools
of strategic intelligence are the science and technology foresight, innovation policy evaluation,
and technology assessment. Yet, despite the large variety of scientometric studies developing
approach for the detection and the analysis of emerging technologies (e.g. Chen, 2006; Ohniwa
et al., 2010; Small et al., 2014), the use of scientometrics for strategic intelligence in the context
of emerging technologies is less explored.
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The present paper aims to illustrate the extent to which a recently developed stream of user-
driven and interactive scientometric mapping techniques, namely overlay mapping (Rafols et al.,
2010), qualifies as a tool of strategic intelligence for the governance of emerging technologies.
The key principle of these mapping approaches is to project data representing a focal subject
area over a basemap, which represents the totality of contemporary activity in scientific and
technological outputs at the considered time. The overlay can be constructed to represent
the knowledge production of individuals, organisations, communities, or entire emerging fields
in science and technology. Those techniques can be applied longitudinally to inform about
the dynamics of emerging technologies across the geographical, social, and cognitive spaces of
emergence as well as on combinations of those. For example, an organisation’s publishing and
patenting activities can be projected on maps of science or Google maps across diﬀerent levels
such as journals, patent classes, or research topics (e.g. Klavans and Boyack, 2009; Leydesdorﬀ
et al., 2014, 2013; Waltman and van Eck, 2012).
We conduct our empirical analysis on three illustrative case-studies of emerging technologies
in the biomedical domain. The case-studies are used as ’vignette’ to illustrate the ’intelligence’
potential of the outputs overlay mapping approaches allow generating. The mapping on the se-
lected case-studies is carried out since early phases of emergence and over decades of observation
by using publication and patent data.
Results shows the diﬀerent types of informed perspectives on emergence overlay mapping
can generate with relative low eﬀorts of analysts and decision-makers. These include urban ar-
eas producing the large amount of knowledge as well as the knowledge of higher future impact,
geographical distribution of the key organisational actors in collaborative networks, and main
scientific disciplines and technological domains involved in the emergence including dynamics
of these. In addition, overlay mappings show flexibility and granularity in the analytical pro-
cess. These tools are flexible in the sense that they are not constrained to the institutional
boundaries of the databases where relevant data are maintained (Griliches, 1994). The informa-
tive perspectives on the emergence can be built by using same or similar search strings across
multiple sources of data. Granularity is provided by the possibility to cross multiple levels of
analysis of the emergence process in order to reveal macro- and micro-dynamics. Flexibility and
granularity also favour the integration and comparison of results from diﬀerent contexts, which
in turn supports the development of a more ’distributed’ strategic intelligence on the emergence
in science and technology.
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The paper is structured as follows. In the next section, we introduce the basic idea underlying
overlay mapping approaches and the diverse possibilities of applications those techniques provide
for the analysis of emerging technologies. We then introduce the three case-studies and data
sources in Section 3. Results are presented in Section 4 and discussed in Section 5. Section 6
concludes the study.
2 Emerging technologies and overlay mapping
The scientometric community has made great eﬀorts in the development of a number of tech-
niques to trace the dynamics in science and technology domains since the seminal works by Price
(1965), Small (1973), Garfield (1979), and Callon et al. (1983). Well established examples of
these methodological approaches are co-citation analysis (e.g. Garfield, 1987; Small, 1973) bibli-
ographic coupling (e.g. Kessler, 1963), and co-words analysis (e.g. Callon et al., 1983; Cambrosio
et al., 2006).
The growing attention to emerging technologies and their transformative power (e.g. Cor-
rocher et al., 2003; Cozzens et al., 2010; Day and Schoemaker, 2000; Martin, 1995) has also led
scientometric scholars to focus their eﬀorts on methodological approaches for the detection and
mapping of emergence in science and technology (e.g. Chen, 2006; Ohniwa et al., 2010; Small
et al., 2014). Those eﬀorts, jointly with the increase of computational power, the improved per-
formance of processing algorithms, the higher technical capabilities in exploiting databases in a
more comprehensive manner, have spurred the development of a number of mapping techniques
among which overlay mapping.
The overlay mapping approach allows, with relatively low eﬀorts of analysts and decision-
makers, rapid investigations across several dimensions and units of analysis of the emergence
process. The basic idea underlying this approach is depicted in Figure 1. Data (mainly of
publications and patents) gathered to represent an entity’s activity in science and technology
domains are used to construct an overlay. This is projected over a basemap representing both
the totality of contemporary activity in scientific and technological outputs at the time, and
the more stable structure of these in the background (e.g. Rafols et al., 2010). An entity
may specifically refer to individuals, organisations, communities, or, especially for the focus of
this paper, entire emerging fields in science and technology. Basemaps can be used to trace
emergence across three diﬀerent spaces, that are, the geographical, social, and cognitive spaces.
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Figure 1: Overlay mappings: approach and spaces of emergence
These include geographical maps, inter-organisational networks, maps of science representing the
entire structure of science at multiple levels of analysis such as disciplines, journals or topics,
and maps of technological areas as identified by patent classes. These spaces of emergence were
initially specified as the main dimensions in early scientometric projects (e.g. Narin, 1976; Small
and Garfield, 1985) and related initiatives led by researchers in science and technology innovation
studies (e.g. Irvine and Martin, 1985) and patent analysis (e.g. Jaﬀe and Trajtenberg, 2002).
We argue that overlay mapping can complement the existing set of more conventional tools
of strategic intelligence for the policy-making of emerging technologies. These mapping tech-
niques can generate evolutionary perspectives to potentially reveal intentional and unintentional
government arrangements among factors and actors involved in the emergence process. Those
informative perspectives may historically and timely inform analysts and decision-makers on
relevant dynamics of emergence such as main geographical areas involved in the knowledge pro-
duction processes and collaborative interactions among those, main actors in inter-organisational
networks and their geographical distribution, domains of science and technologies involved in
the emergence and associated dynamics across disciplines, journals, technological classes, and
(in the case of biomedical technologies) medical areas. The increased knowledge on emergence
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overlay mapping may provide the policy-making process with can in turn support the develop-
ment of forms of governance that are more capable to cope with the uncertainty, ambiguity, and
rapid dynamics of emergence.
Flexibility in the use of diverse sources of data and granularity in the multiple levels of anal-
ysis are additional features that qualify overlay mappings as a tool for a ’distributed’ strategic
intelligence on emerging technologies. Results of the analyses and associated knowledge from
diﬀerent contexts can indeed reflexively and discursively be integrated and compared with rela-
tive low eﬀorts. The choice of overlays and basemaps as well as combinations of them however
depends on the specific question(s) the analyst or decision-maker aims to address.
To examine the use of overlay mapping as tools of strategic intelligence for the governance
of emerge in science and technology, we first summarise and then apply a number of overlay
mapping techniques, that have been developed and reviewed in the domain of the information
sciences and scientometrics, on three case-studies of emerging technologies. Methodologically,
we rely on previous works some of the authors of this paper have conducted. We specifically
build on (i) Leydesdorﬀ and Persson (2010) for mapping co-authorship relations in publications
as overlay to Google Maps, (ii) Rafols et al. (2010) for mapping publications in terms of Web of
Science (WoS) Categories, (iii) Bornmann and Leydesdorﬀ (2011) for the mapping of excellence
in publications, (iv) Leydesdorﬀ and Bornmann (2012) for the equivalent mapping of patents,
and (v) Leydesdorﬀ et al. (2012) for mapping medical innovations in terms of Medical Subject
Headings (MeSH).1
3 Methods
3.1 Background on the case-studies
We conduct our analysis on three-case-studies of emerging technologies in the biomedical domain:
(i) RNA interference (RNAi), (ii) cervical cancer testing technologies for Human Papilloma Virus
(HPV) and (iii) genetic testing for the Thiopurine Methyltransferase (TPMT) enzyme. These
case-studies were selected since they exhibit diversity in terms of their contexts and positions in
the innovation chain. From a governance perspective, each technology raises diﬀerent challenges:
1 Reiterating the full technical details of these methods goes beyond the scope of this paper. The reader is referred
to the relative studies and corresponding webpages. In addition, it is worth noting that these methods build
on a broader set of contributions on S&T mapping for policy use (e.g. Bo¨rner, 2010; Noyons, 2005, 2001).
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RNAi is a new technology with radical potential across the domains of therapeutics, diagnostics
and as a basic research, but with fluctuating industrial interest; HPV testing is battling the
entrenched technology of Pap testing, with powerful interest groups on both sides; TPMT testing
technologies are exploited in a series of small clinical niches, mainly in developed countries where
there are concerns that best practice may not be spreading. This variety provides us with the
opportunity to enrich our discussion the use of overlay mapping to generate ’intelligence’ inputs
for the governance of emerging technologies. In the followings, we provide background sketches
for the case-studies to contextualise the scientometric maps presented later in the paper.
Firstly, RNAi is a molecular process that can silence the expression of genes. Genes play a
critical role in the progression of cancers, genetic diseases, and infection agents. Theoretically,
by silencing specific genes one can stop the progression of a given disease. This ’small RNA’
silencing mechanism was discovered in 1998.2 Its discovery reshaped the landscape of research
on gene expression creating important expectations especially for the therapeutic applications
(Sung and Hopkins, 2006). RNAi can be conceived as a general purpose technology for research
in labs.
Secondly, HPV testing technologies are positioned within a specific domain of application,
i.e. the detection for HPV virus, which is recognised as causing cervical cancer.3 Cervical
cancer has a significant disease burden — about 500,000 new cervical cancers occur and cause
about 250,000 deaths worldwide each year. This has led to the development of a large screening
program, especially in developed countries.4 In the US mote than 100 million tests are performed
annually.5 While cervical cancer screening has been conducted for more than 50 years using the
(cytology-based) Pap test to detect cancerous cells or cells potentially evolving in cancerous
states, the discovery of the strong association between HPV infections (especially HPV types 16
and 18) and cervical cancer in the 1980s opened the space for the development of a competing
and more sensitive testing technology based on molecular biology (Hogarth et al., 2012).
Thirdly, similarly to HPV test, TPMT testing technologies are positioned close to the
2 Andrew Z. Fire and Craig C. Mello were awarded the 2006 Nobel Prize in Physiology or Medicine 2006 for this
discovery (Fire et al., 1998).
3 Harald zur Hausen 1987, who discovered the association between the HPV and cervical cancer, was awarded
the 2008 Nobel Prize in Physiology or Medicine.
4 Cervical cancer remains however one of the most common cancers among women in developing countries that
account for about 85% and 88% of new cases and deaths, respectively (GLOBOCAN 2008 available at http:
//globocan.iarc.fr.
5 Health United States 2012 — Technical report.
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applied-research domain. Yet, its application for clinical utility is contested across medical
fields (e.g. diﬀerent clinical guidelines supporting and discouraging the use of the test). TPMT
testing is one of an emerging class of ’pharmacogenetic tests’ which predict adverse events asso-
ciated with pharmaceutical use (Hopkins et al., 2006). TPMT is an enzyme in the human body
responsible for metabolising (i.e. breaking down) thiopurine drugs. Cytotoxic thiopurine drugs
such as ”Azathioprine” are used to treat a range of conditions including leukaemia, and autoim-
mune diseases (such as Lupus, or rheumatoid arthritis). However, when a patient has mutations
in the gene encoding TPMT, she/he is unable to metabolise the drug and is at increased risk of
toxicity from a build-up of thiopurines. Therefore, several types of TPMT testing technologies
have began to emerge with applications across a number of clinical fields of use such as oncology,
dermatology, gastroenterology, and rheumatology.
3.2 Data sources
Data were collected from multiple databases. We relied on Thomson-Reuter’s Web-of-Science
(WoS) and MEDLINE/PubMed for publication data, and on the United States Patent and
Trademark Oﬃce (USPTO) for patent data. These databases were queried with a set of keywords
we identified by triangulating interviews with experts and quantitative research works on the
case-studies (see Table 1). The interviews with experts in the fields of the selected case-studies
are also used as lens of interpretations of the results we obtain from the application of overlay
mapping approaches.
The retrieval of data for emerging technologies is challenging. Research topics often overlap
and the vocabulary they use is in flux. Recently developed methods for retrieval rely on com-
bining lexical search and clustering citation methods (Zitt and Bassecoulard, 2006), yet these
approaches would be time-consuming for the analyst. We therefore deemed more suitable to
use keyword-based searches given the parsimony and timeliness of the approach. We limited
the search of keywords and their combinations in scientific articles’ titles since this approach
tends to generate less false positives compared to the searching in articles’ abstracts. Abstracts
indeed often contain technical and methodological terms not representing the core of knowl-
edge the given article claims (Leydesdorﬀ, 1989). An extended search may generally retrieve
many additional records, yet with the risk of including many ones not closely related to the
given emerging technology one aims to trace — it increases ’recall’ at the expenses of losing
’precision’, in bibliometric technical terms.
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The identification of patents that are relevant for the building of informative perspectives
on emerging technologies requires a diﬀerent approach. The incentives to patent are indeed
diﬀerent from those underlying the publication of scientific articles (Murray, 2002). The primary
purpose of the patent system is to reward patentees by providing them a temporary monopoly
to commercially exploit the patented inventions. Yet, this requires patentees to disclose the
technical knowledge of the inventions. In this regard, patent attorneys are very careful in
including valuable information in the appropriate sections of patents. Among these sections,
claims are the most relevant source informing on the scope of the technical knowledge (Hunt
et al., 2007). Claims ”define the invention and are what aspects are legally enforceable” (USPTO
Glossary).6 We therefore focus the search of keywords on the claims in patents. Issues related to
the definition and delineation of the boundaries of emerging technologies are further discussed
in the next section.
The number of publications and patents that relate to each of the three cases, from 1982
to 2011, are reported in Table 2. While the first publications related to TPMT and HPV stem
from the early 1980s, data for RNAi appears only since 1998 when this silencing mechanism was
discovered and first published. Publication data from WoS and MEDLINE/PubMed allow for
relatively simple but informative reports on the rapid emergence of these three technologies in
terms of published scientific articles. The fast growth provide evidence of the emerging character
of the selected technologies (Cozzens et al., 2010). It is clear that the pace of this growth as well
as the scale of this emergence is significantly diﬀerent from one case to another in two respects.
First, the growth in the number of publications for RNAi is steeper than the other two case-
studies. Second, RNAi and HPV testing technology show an increasing number of publications
for the entire observation period. Conversely, the testing technology for TPMT enzyme seems
to have reached its mature phase in the last few years of observations.
Patent data reveal similar distinctive features. The production of patents (both granted
patents and patent applications) related to RNAi, for example, is relatively much greater than
in the case of HPV and TPMT testing technologies. This is not surprising given the former’s
wide potential of applications. The declining of the patenting activity related to RNAi in the
last two years of observation is mainly due to the USPTO publishing patent applications after
18 months from the filing date. Although most patenting in RNAi occurs in small firms, the
6 The USPTO Glossary is available at http://www.uspto.gov/main/glossary.
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decision of some large pharmaceutical companies, including Merck, Roche and Pfizer, to shut
down their R&D units on RNAi may have also resulted in a decreased interest on RNAi and
contributed to this decline (Lundin, 2011).
The patent application activity around HPV testing technology grows from 2002 to 2004
and then stabilises in the subsequent years with a peak of applications in 2009. The low number
of granted patents and patent applications for TPMT testing technology does not allow clear
trends in the production of technical knowledge to be deduced, other than to note this is a less
vigorous field.
3.3 Definition and delineations issues
A key preliminary input for the use of mapping and overlay techniques is the identification of
the boundary of emerging technologies. In general the definition of a technology is more am-
biguous than one may initially expect. An emergent technology can be defined as the knowledge
underpinning method or processes to fulfil a purpose (e.g. understanding of gene silencing) or
as a network of practices and components (e.g. the molecules and techniques that result in gene
silencing). The case of RNAi is apt to highlight the ambiguity inherent in the delineation of the
boundary of emerging technologies.
RNAi is the naturally occurring process in which gene expression is reduced as a result
of the break down of messenger RNAs. This process can be triggered by naturally occurring
(endogenous) molecules, called microRNAs (miRNAs), or by externally inserted (exogenous)
molecules, called small interfering RNAs (siRNAs). Soon after the discovery of RNA interference
by Fire et al. (1998), siRNAs were recognised as valuable for gene silencing, both as tools
for research and for therapeutic purposes, which lead to a boom in public and private R&D
investments (Haussecker, 2008, 2012). In parallel, but with some significant delay, it was realised
that miRNAs were not a marginal phenomenon, but played a major role in gene regulation,
including abnormal down or up regulation in certain diseases caused or earmarked by anomalous
gene expression, such as many cancers.
In principle, then, research on the science and technology of RNAi should include both
siRNAs and miRNAs. However, it turns out that ’RNA interference’ as a technology (not as
phenomenon) has become mainly known as the human-induced, exogenous interference, which
was developed for therapeutic purposes. We then have two potential definitions of RNAi, one
covering the entire field and one excluding miRNA — commonly adopted for the discussion of
12
Figure 2: Delineating the boundary of RNAi. Scientific articles related to miRNA were retrieved by using
the following search string in WoS: ’TI=microRNA* or TI=miRNA*’.
therapeutic applications.
Figure 2 illustrates that the observed dynamics are diﬀerent. Whereas miRNA research
is still booming, possibly due to their potential use as biomarkers in diseases such as cancers,
publications focused on siRNA have reached a plateau of about a thousand publications per year.
The latter is possibly related to the challenges encountered in delivering siRNA in therapeutic
applications that resulted in a retreat of pharmaceutical investment (Haussecker, 2012). These
diﬀerences in trends support the views that the use of miRNAs and siRNAs follow distinct
trajectories, which it is best to diﬀerentiate. In this study, we focus on RNAi as research tool
and for therapeutic applications, i.e. not including miRNA.
4 Results
The use of overlay mapping approaches as tools of strategic intelligence for the policy-making
process is discussed below. We specifically build perspectives on the emergence process of
the aforementioned three illustrative case-studies across the geographical, social, and cognitive
spaces. Due to space limitations, we discuss and report in the paper a sample of the results
obtained — the entire set of maps and overlays is available as supplementary materials, which
include interactive features, at www.interdisciplinaryscience.net/overlaymapping.
13
4.1 Tracing emergence in the geographical space
One can combine the use of overlays with geographical (base)maps to visualise, by using pub-
lications and patent data, the emergence process across cities, regions, and nations. Building
on previous works (e.g. Bornmann and Leydesdorﬀ, 2011; Bornmann and Waltman, 2011; Hu
et al., 2012; Leydesdorﬀ and Bornmann, 2012), one can, for example, identify sites for a given
emerging technology where highly cited scientific articles were published more frequently than
expected. This is depicted in terms of the sizes and colours of nodes.7
For the three case-studies of this article, we used overlays projecting publication data accord-
ing to a 5-year time window.8 Using constant time windows across the case-studies allows us
capturing the diﬀerent paces at which the diverse selected emerging technologies have emerged
in terms of (WoS) publications. Figure 3 depicts the results applied to HPV and TPMT testing
technologies during the period 2002-2006.
For the case of HPV testing technologies, these maps identify, over the entire observation
period, European urban areas producing highly cited scientific knowledge more frequently than
expected in London, Paris, and Amsterdam. New areas have also started to appear both in the
North (nearby Copenhagen, Helsinki, and Jena) and South (nearby Barcelona, Bologna, and
Turin) of Europe since the mid-1990s. The US sites contributing to this emerging technology
with highly cited articles are mainly located on the coasts, specifically in the area of Washington
D.C., Baltimore, New York, and Boston, for the East Coast, and near San Francisco and San
Diego for the West Coast. Georgetown University and the private company Digene in the area
of Washington D.C. have played a key role for the development and the adoption of a test for
the HPV detection in cervical cancer screening (Hogarth et al., 2012). The maps also reveal the
rise of new sites producing highly cited scientific knowledge in South America (e.g. near Sao
Paulo, Buenos Aires) during the last ten years of observation.
This geographical mapping for TPMT testing technology locates, at the beginning of the
observation period, highly cited articles in the urban areas of Rochester and Memphis (US) as
well as Sheﬃeld (UK). However, as for HPV testing technology, new sites have started to appear
7 The z− test for two independent proportions is used. The null hypothesis is the randomness in the selection of
papers for a city (see Bornmann and Leydesdorﬀ, 2011). A threshold of top 10% most-frequently cited scientific
articles is selected.
8 Similar dynamics are observed by using narrower/broader time windows (e.g. 3-year, 7-year). It is worth noting
that in order to exploit all the available data up to year 2011 the first time window for RNAi is 1998-2001,
i.e. four years of observations. RNAi can indeed be observed starting from year 1998 when this gene silencing
mechanism was discovered (Fire et al., 1998).
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Figure 3: Areas of highly cited publications for the 2002-2006 period. Nodes are coloured dark green
(red) when the diﬀerence between the observed number of top-cited publications and the expected one
is positive (negative) and statistically significant (p < 0.05), light green (orange) otherwise.
since 1997 close to the East and West coasts (e.g. areas of Washington D.C., Boston, San Diego,
San Francisco), across the UK (e.g. near London, Glasgow, Edinburgh) and Europe (e.g. Berlin,
Madrid, Seville).
In the case of RNAi, the mapping shows the emergence of urban areas producing highly
cited articles on the East Coast of the US near Baltimore and New York, and, especially, in
the area of Boston (see supplementary materials). The RNAi mechanisms were discovered by
groups of scientists working in Massachusetts (Haussecker, 2008). However, while the maps in
the subsequently years report the emergence of many sites all round the world, Massachusetts
has persisted as the main area producing highly cited scientific articles — this is revealed by the
size of the node and as one of the hubs for RNAi biotech firms.
Interesting dynamics can be observed by combing these findings with those obtained using
a similar approach but geo-localising patent data.9 These maps are reported for the 2002-2011
period in Figure 4 — the first time window (1998-2001) is excluded because there are only
9 For this approach, we decreased the threshold from top 10% (as used for publication data) to the top 25%
cited patents, necessary because the number of publications is an order of magnitude higher than the number
of patents (Leydesdorﬀ and Bornmann, 2012).
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11 patents, which constitute a too small sample for the statistical analysis.10 While the area
of Denver has emerged as one of the many urban areas of high citation for the production of
scientific knowledge in the later period of observation, these maps show this area producing
highly cited patents more frequently than expected. These patents related to the reagents used
in RNAi (small interfering RNAs) while patents produced in centres nearby New York and
Philadelphia related to therapeutic applications. The analysis does not identify any urban area
of high citations in Europe or Asia.
Figure 4: Areas of excellence (patent-based) for RNAi for the 2002-2011 period. Nodes are coloured dark
green (red) when the diﬀerence between the observed number of top-cited patents and the expected one
is positive (negative) and statistically significant (p < 0.05), light green (orange) otherwise.
This analysis shows how overlay mappings can provide the policy-making process an analyst
is undertaking with relevant inputs such as the list of geographical areas where main advance-
10For this reason, these maps cannot be built for the HPV and TPMT testing technologies.
16
ments for a given emerging technology were achieved and areas that are ’unexpectedly’ listed.
It may also inform on areas that persistently contribute over time to the development of the
emerging technology as well as on new emerging ones. De facto coordination arrangements
are also revealed. For example, the maps for HPV and TPMT testing technologies identify
a number of urban areas in which highly cited publications concentrate as located developing
countries (see supplementary materials). A further analysis on the collaboration networks (see
below) revealed co-authorship links between these areas and others leading the advancements of
these emerging technologies in the developed countries. These collaborations may have provided
developing countries with the access to critical capabilities and resources to produce novel and
high-quality knowhow, but perhaps indicating some crucial contribution (e.g. a genetic resource
or patient population) needed by researchers in developed countries too that was helpful.
It is important to note some limitations of the above-discussed approaches. Firstly, the ge-
ographical information reported in publication and patent data may not reflect the locations
where the research was conducted. This is especially true when patent data are considered.
Inventors list their home addresses which may not necessarily reflect the geographical locations
were inventions were developed. Secondly, while the overlays built at city-level provide granular-
ity, they can represent sites located in the same urban area as two diﬀerent nodes. For example,
in the case of HPV testing technology, Silver Spring (a suburb of the US capital) was considered
as a node diﬀerent from Washington D.C.. These limitations represent an important venue for
future development of those techniques.
4.2 Tracing emergence in the social space
The structure of the relationships among the actors surrounding emerging technologies and
their dynamics play a critical role in the emergence process (e.g. Latour, 1993; Powell, 1990).
These connections are channels through which actors gain access to and mobilise knowledge,
resources, and power. Networks of agents aﬀect and are aﬀected by emerging technologies, i.e.
actors creates social structures over the emergence that both enable and constrain their actions
(Giddens, 1984). By using co-authorship data (e.g. Crane, 1972; Gla¨nzel and Schubert, 2004;
Wagner, 2008), the dynamics across this relevant space of emergence can be traced. Novel
techniques allow specifically building perspectives crosscutting both the social and geographical
spaces (Leydesdorﬀ and Rafols, 2011).
For example, Figure 5 shows the 2002-2006 collaboration networks at city-level for HPV and
17
TPMT testing technologies. In this map, nodes are cities and the linkages between nodes are
traced by using co-authorship data.11 Investigating the dynamics across these maps may pro-
vide informative perspectives that are derived by combining the geographical and social spaces.
Examples of key empirical questions the overlay mapping approach may help to address in the
policy-making process are: Where does an emerging technology arise? Does the collaboration
network cluster in specific areas? Does the given emerging technology spread across cities, re-
gions, and countries and, if yes, through which (collaboration) channels — which types of grant
were important, which size of institutions, or types of knowledge brokers?
The collaborative network of HPV testing technologies, for example, discloses three relevant
dynamics of the emergence process. First, a strong collaborative activity between the US (espe-
cially the areas of Washington and New York) and Europe (initially Germany) can be observed.
This technology indeed started to emerge after a scientist, Harald zur Hausen, at German Cancer
Research Centre proved HPV infections to be strongly associated with the development of the
cervical cancer (zur Hausen, 1987). This discovery subsequently found important application
in the US where extensive screening programs on cervical cancer were already in place. Here,
a small biotech company, namely Digene, developed and marketed a series of FDA-approved
HPV tests, which are recognised as significant milestones in the management of cervical cancer.
Second, the last ten years of observation show an increasing involvement of developing countries
(e.g. Brazil, India) in the research networks. Cervical cancer in these countries is a signifi-
cant social burden. HPV is sexually transmitted and the costs associated with the screening
of the population are not always aﬀordable. Third, globalisation of research on HPV testing
technologies can be observed across the entire period as revealed by the density of the network
of relationships across cities. The latter dynamic is also observed in the case of RNAi that
diﬀuses all round the world, even more rapidly than HPV and TPMT testing technologies (see
supplementary materials).
In the case of TPMT testing, further informative dynamics are revealed. The co-authorship
network evolves starting from a strong collaboration between Rochester (US) and Sheﬃeld
(UK). This collaboration intensifies over the entire observation period while major collabora-
tive networks within the UK and US national boundaries formed later, only since the 1990s.
11Similar maps can be also built with the top-cited publications approach we described in the previous section.
This provides additional perspectives on the structural position cities producing highly cited knowledge occupy
in the web of collaborative relationships (co-authorships). We made these maps available for the three case-
studies as supplementary materials.
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Subsequently, from 1997, we observed also the rise of the European network initially involving
Germany, France, The Netherlands, and UK, and then including other countries such as Italy
and Spain.
Building on these crosscuttings of the geographical and social spaces, one can focus more
attention on the social dynamics by looking at the structure of the web of relationships composing
the network at a lower level of analysis such as the organisation-level. The network can be
explored with algorithms that identify cohesive groups of organisations as well as public and
private players occupying key positions. The network analysis provides a broad range of measures
for this purpose (Wassermann and Faust, 1994).
For example, the lower part of Figure 5 depicts the organisational collaborative networks cor-
responding to the aforementioned collaborative networks overlaid on the geographical space.12
While for HPV testing technologies a giant component of the network can be identified, the
organisational network for TPMT testing is highly fragmented, as revealed by the diﬀerent sep-
arated groups of organisations (components), until the last five years of observation (Table 3).
For clarity of the representation, Figure 5 depicts the largest component for HPV testing tech-
nology for 2002-2006 period. We instead represented for TPMT testing technology components
formed by at least three organisations.
The dynamics of the collaborative network surrounding the research activity on HPV testing
technology show Digene occupying a strong and influential position within this network by
collaborating with major institutions in the field of cervical cancer screening (e.g. National
Cancer Institute, a public sector sponsor, and Kaiser Permanente, a large healthcare service
provider and early test adopter). This eventually allowed Digene to influence the adoption of
the test, for example by working with clinicians involved in the definition of medical guidelines
(Hogarth et al., 2012). In other words, while Digene’s activity was ’regulated’ by the FDA for
example, Digene was aﬀecting the developments and dynamics in cervical cancer screening, too.
As discussed, the co-authorship network for TPMT testing technology is characterized by
the presence of several separate components over a significant part of the observation period.
12Organisations’ names included in publication data of WoS present a number of variations, i.e. the same organi-
sation may be spelled in diﬀerent manners. We use The Vantage Point software to clean the data. This software
specifically analyses and suggests groups of names that may refer to the same organisation by using a fuzzy
algorithm that exploits also the information included in other fields of the publication data. We checked those
suggestions for our sample of publications and confirmed those matches for which the manual desktop search
over the Internet provided further support. Freeware routines for using institutional addresses but without this
cleaning process can be retrieved at www.leydesdorff.net/maps.
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The network seems to initially develop around the strong collaboration between Mayo Clinic
(Rochester, US) and University of Sheﬃeld and subsequently around three actors, who played a
key role for the creation of a large network component in the later years of observation. These
actors are St. Jude Children’s Research Hospital, University of Manchester, and Dr Margarete
Fischer Bosch Institute. Further analysis of the content of publications and patent data revealed
St. Jude Children’s Research Hospital as conducting fundamental basic research in this domain
as well as developing strong IP by holding key patents on genetic mutations used in TPMT
testing, University of Manchester focusing on the issues related to the cost-eﬀectiveness of using
TPMT testing technology, while the Dr Margarete Fischer Bosch Institute — a large research
foundation working on the customisation and improvement of drug therapy — hosted staﬀ that
held together a wider collaborative network through personal links (e.g. visiting fellowships) at
other major centres in the field.13
The above discussed cases and techniques combined the geographical and social spaces of
emergences and moved across units of analysis, in this case from the city- to the organisation-
level. This provides a clear example of the flexibility and granularity of the overlay mapping in
providing intelligence on the constellations of actors involved in the emergence process, structure
of the relationships among these actors, key actors and collaborations shaping the emergence as
well as main channels where knowledge and resources may flow.
4.3 Tracing emergence in the cognitive space
As new technologies emerge, epistemic developments occur in terms of discoveries, novel theories,
or changes in technical developments such as experimental systems, materials, methods, and
instrumentation (Joerges and Shinn, 2002; Rheinberger, 1997). These dynamics can be traced
across the cognitive space by creating overlays of publications on basemaps of science that can
be defined at diﬀerent levels of analysis (e.g. Klavans and Boyack, 2009; Waltman and van Eck,
2012).
The publishing activity related to three case-studies can be, for example, projected across
the map of science defined by the 225 WoS categories (e.g. Rafols et al., 2010). In this map, each
node is a WoS category that can be assumed as proxy of a scientific discipline. The projection
(overlay) makes a node’s size proportional to the number of publications related to the given
13The dynamic collaborative networks of the three case-studies are also included as supplementary materials.
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technology that were published in the given discipline the node represents. The diﬀerent colours
of nodes represent diﬀerent clusters of disciplines. Figure 6 depicts the projections of publications
related to the three case-studies. We report the map representing the structure of science (left)
— the strength of each linkage is proportional to the extent to which the two disciplines cite each
other — and the heatmap version (right).14 This combination provides an intuitive visualisation
of the diﬀusion process of emerging technologies.
As for the previous analyses, we used overlays projecting the publishing activity according
to 5-year time windows. While these maps show the rapid diﬀusion of RNAi technology across
many disciplines such as molecular biology, oncology, biomedical research, and chemistry, the
overlays of HPV and TPMT testing technologies reveal diﬀerent directions of diﬀusion. HPV
testing technology diﬀuses from basic research in oncology, pathology, and virology disciplines
towards issues related to the public health. We interpret this dynamic as a representation of
the extensive and ongoing debate on the practices adopted for the screening of the population.
The debate has been focused on the suitability of HPV testing technology as first an adjunct
to, and latterly a substitute for, the widely adopted Pap test (Hogarth et al., 2012).
TPMP testing technology diﬀuses from the basic research in pharmacology towards, inter
alia, gastroenterology and dermatology clinical disciplines. Publication activity seems to equally
spread in gastroenterology and dermatology disciplines during the 1992-1996 period. Yet, in the
subsequent years, the volume of publications shrinks from dermatology area while continuing
to grow in gastroenterology. This raises questions about the degree to which TPMT’s use has
been contested in the diﬀerent communities such as gastroenterologists, rheumatologists, and
dermatologists.
It is worth noting that the techniques we have presented so far also suggest avenues of
investigation an analyst may want to pursue for a more informed policy-making process. For
example, we followed the aforementioned dynamic by conducting an additional analysis of the
content of the scientific articles published by these communities. One potential conclusion may
be that less publication in dermatology suggests failure to adopt. However, this is not the case.
More fine-grained analysis of journal article titles and abstracts showed that while the community
of dermatologists broadly accepted the validity of TPMT test, this test is still highly contested
in the communities of rheumatologists and, especially, gastroenterologists. This more intense
14The visualisations of cognitive maps were produced by using VOSviewer 1.5.4 (van Eck and Waltman, 2010).
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debate that is captured by the cognitive mapping approach is also testified by the strongly
worded titles of scientific articles and presence of a large number of author response/reply or
comment articles to other articles that these two communities published.
A similar cognitive perspective can be built by using a map of which nodes represent academic
journals (Leydesdorﬀ et al., 2013). The map is specifically composed by 10,330 journals (nodes)
— the diﬀerent colours of nodes represent diﬀerent cluster of journals, i.e. groups of journals
of which the cross-citation patterns are similar. Figure 7, for example, illustrates the rapid
diﬀusion of RNAi across this map. RNAi has specifically started to appear in journals in the
basic biomedical science and subsequently it has diﬀused among a variety of discipline-specific
journals. The Rao-Stirling diversity index (Stirling, 2007), measured on the set of journals of
the map, provides further evidence of this rapid diﬀusion, especially when the index is compared
with the other two emerging technologies on which we focused our analysis.
Figure 7: Journal map for RNAi and diversity index.
Perspectives on the cognitive dynamics can be also built by using MeSH terms — terms
used to characterise the content of scientific articles in life science. These terms are assigned
to articles in MEDLINE/PubMed through an intensive indexing process that is performed by
examiners at the National Institute of Health (NIH). The terms are organised in a 16-branch
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tree, which can reach up to 12 levels of depth. Drawing from this classification, Leydesdorﬀ
et al. (2012) developed a MeSH map by using three branches: ”Diseases”, ”Chemicals and
Drugs”, and ”Analytical, Diagnostics and Therapeutic Techniques and Equipment”. These can
be interpreted as ’supply-side’, ’demand-side’ and ’infrastructure’, respectively. The first two
levels of the tree were selected to build the basemap. The map is specifically composed by 822
MeSH terms (nodes) of which linkages reflect the (cosine) similarity according to co-occurrence
of these terms in scientific articles. Each branch is marked on the map with a diﬀerent colour:
”Disease” is coloured red, ”Chemicals and Drugs” green, and ”Analytical, Diagnostics and
Therapeutic Techniques and Equipment”” blue (see Figure 8). Similarly to previous approaches,
the publishing activity characterising a given emerging technology can be projected on this map
to trace dynamics across three branches of the MeSH tree.
This approach, applied to the three case-studies, revealed diﬀerent dynamics. RNAi, in
line with previous results, ’globalises’ across the set of the MeSH terms thus aﬀecting many
areas of the represented branches. On the contrary, HPV testing technology diﬀuses from the
”Diseases” branch, specifically from ”Tumor Virus Infections”, into the ”Analytical, Diagnostics
and Therapeutic Techniques and Equipment” branch and eventually across the ”Chemicals and
Drugs” area. Yet, interestingly, in the last time window (2007-2011 period) scientific articles
on HPV testing technology concentrate in the techniques and equipment area. This may reflect
the eﬀorts in developing competing HPV testing technologies. Results also show a specialisation
of the TPMT case-study in specific areas of the map. This is in line with the scale of TPMT
testing technology that is limited to a narrow domain of application.
Tracing the patenting activity of emerging technologies provides additional perspectives on
the cognitive dynamics of the emergence process given the diverse incentives featuring in the
creation process of scientific articles and patents. Scholars have developed techniques also to
trace the dynamics of the patenting activities (e.g. Kay et al., 2014; Schoen et al., 2012). The
nodes of these maps are technological classes that, as in the case of previous maps, are linked
by cross-citation (cosine) similarity (Leydesdorﬀ et al., 2014).
Figure 9, for example, depicts the overlays of RNAi patenting activity on the patent map
based on technological areas as defined by the International Patent Classification (IPC). One
can trace the dynamics in this space by moving across diﬀerent levels of the classification (e.g. 3-
digit, 4-digit). The patent map visualisation revealed the patenting activity of RNAi focused in
specific areas of the technological space as biochemistry, organic chemistry, and medical science.
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Figure 8: Overlay of the publishing activity across the map of MeSH terms.
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While one would expect to observe intense patenting in these technological areas given the nature
of RNAi, this also reveals how one may need to increase, from case to case, the granularity of the
mapping (i.e. lower levels of IPC classes) to build informative and interpretative perspectives
on the observed emerging technology.
Mapping the emergence in the cognitive space may therefore reveal a number of relevant
dynamics. These include the directions of diﬀusion of the given emerging technology across the
key knowledge areas involved in emergence, how those areas may integrate or misalign, in which
domains actors’ knowledge production processes are positioned, or, for medical innovation, what
diseases a technology is addressing and by using what type of techniques and chemicals.
5 Discussion
In cases of the emergence of novel technologies, all actors and even more so policy makers have
very incomplete knowledge, not knowing, for example, where the boundaries of the technology
are, in which direction it is moving, and how it should move forward. In the face of uncertainty,
ambiguity, and ignorance (Stirling and Scoones, 2009), the emergence process should be inves-
tigated and analysed with strategic intelligence tools able to support a more informed policy-
making process. In this article, we have presented a variety of overlay mapping approaches,
applied those on three case-studies of emerging technologies in the biomedical domain, and
shown the variety of ’intelligence’ inputs for the policy-making process they can generate.
One of the advantages of those techniques is to not rely on single perspectives of the emer-
gence, which would be misleading since relevant contexts would be inevitably omitted being
emergence a complex and multi-faceted process. The mapping allows instead conduct a multi-
perspective analysis on emergence and associated dynamics across the geographical, social, and
cognitive spaces and combinations of these. Overlay mapping can be therefore conceived as a
control system for emerging technologies that by monitoring emergence and synthesising the
complex information deriving from it in relative simple visualisations can potentially favour
the development of governance of a higher scope, speed, accuracy, and reliability (Nightingale,
2003). However, the flexibility and granularity of the mapping make its eﬃcacy and eﬃciency
to serve as a strategic intelligent tool dependent on a set of choices the analyst makes — some
choices that may seem eminently technical (e.g. level of aggregation) may also have important
implications for the type of patterns one can observe.
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Figure 9: Patent map (IPC-based) for RNAi.
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Firstly, a key preliminary choice is to identify the boundary of emerging technologies, i.e. the
delineation of the corpus. Deciding what to include and what to exclude in the analysis is always
a problematic exercise in the case of emergent sciences and technologies. In the case of RNAi, for
example, one type of delineation portrayed this technology as already having reached a mature
phase, whereas a broader definition suggested RNAi in a phase of rapid growth (Figure 2).
Secondly, the analyst has to identify the data sources. It is clear that using bibliographic
data from publications and patents yields diﬀerent types of information. Yet, those are only one
form of research outputs. Many other possible dimensions such as products, services, changes in
healthcare outcomes are not easily accessible for the mapping. This implies that some emerging
technologies will be well represented in certain datasets and not others. This may also be the
case for certain groups of actors — for example, academic organisations may publish more and
patent less than private organisations, who may behave in the opposite manner. Consideration
of available datasets places a considerable onus on the analyst to find appropriate sources and
not to over-interpret limited data from less appropriate sources. Studying biotechnological
innovations in an IP dominated industry, where regulatory and peer community pressures ensure
publication, is a considerable advantage from the point of view of data access and availability.
However, other contexts may not be so well provisioned, with implications for the utility of the
approaches discussed here.
Thirdly, the selection of the elements to be analysed from the records of the databases as
well as the categories into which the elements are assigned may have a significant impact on
the resulting analyses. From a patent record, for example, one can extract information about
inventors, firms, technology classes, or location, which, as discussed, provide insights on the
social, cognitive or geographical spaces of emergence, respectively. In the case of categories one
needs to decide the level of aggregation (the granularity of the description) as well as the type
of classification — i.e., whether a predetermined, top-down typology is used (e.g., the MeSH
terms) or an emerging, bottom-up taxonomy.
The choices of databases, elements, and categories can be informed by conceptual and the-
oretical frameworks that suggest why taking some perspective can be more fruitful than others
to trace emerging technologies. However, from a policy analyst’s standpoint, it may be also
critical to monitor technological emergence even when there is lack of an explicit understanding
of conceptual frameworks used — policy is needed under conditions of incomplete knowledge.
Yet, even in these cases in which there is no explicit adoption of a conceptual framework, the
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choice of certain elements and categories in the analysis is privileging certain understanding over
others, and this it is implicitly using the corresponding conceptual framework.
For example, looking at collaborative networks of individual scientists may place more at-
tention on the social capital as a key factor in the emergence process (Nahapiet and Ghoshal,
1998). If one looks at the disciplinary position of the technology it is likely to be assuming that
integration of disparate knowledge is relevant as, for example, it has been perceived to be the
case of nanotechnologies (e.g. Porter and Rafols, 2009; Schummer, 2004) and in RNAi (Ley-
desdorﬀ and Rafols, 2011), but not necessarily in HPV or TPMT testing technologies. In the
absence of a clear understanding of the technology, one is advised to explore the phenomenon
by using several perspectives, because one does not know in advance which one may turn out
to be useful for understanding the relations of the emergence in place, or because the area in
which the action is occurring is shifting over time.
Emerging technologies often do not conform to established bodies of knowledge. They cut
across pre-existing organisational and institutional units, challenging established managerial and
policy practices. As a result, one key demand from analysts and decision-makers is a descrip-
tion of the types of interdisciplinarity or convergence evident in emergence (Schmidt, 2007),
often related with specific visions and expectations (Beckert et al., 2007; Roco and Bainbridge,
2002). In this regard, building multiple perspectives on the process of emergence requires moving
across databases where emerging technologies ’tumble’ in terms of representations with diﬀerent
attributes — such as geographical addresses, WoS Categories, patent classes.
The databases are retained and organized in diﬀerent contexts with relative institutional
rigidities. For example, relating patents to publications in terms of ’non-patent literature ref-
erences’ requires professional skills and cannot be done on a large scale without substantive
investments. Thus, while the mapping and overlay techniques allow one using the same or a
highly similar search strings across these databases more research is required in this direction to
increase the integration of datasets. This can already be seen in attempts by US funders such
as the NIH to link research grants, patents and publications.15
15See, for instance, http://projectreporter.nih.gov/reporter.cfm
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6 Conclusions
We contributed to the debate of governance of emerging technologies by showing how over-
lay mapping can function as a tool of strategic intelligence for the governance of emerging
technologies. The outputs produced by this stream of approaches can timely provide histori-
cal and informed perspectives on emergence with relative low eﬀorts of analysts and decision-
makers. Relevant dynamics are illustrated across the geographical, social, and cognitive spaces,
in terms of geographical distribution of knowledge processes, collaborative interactions among
geographical areas and organisational actors, and scientific and technological domains emerg-
ing or involved. Overlay mapping can also crosscut sources of data and move across units of
analysis. These flexibility and granularity favour the comparison of the results from diﬀerent
policy-making contexts thus supporting the use of the mapping for a more ’distributed’ strategic
intelligence on emerging technologies.
We illustrated our argument conducting three case-studies of emerging technologies in the
biomedical domains. The case-studies, being heterogeneous in terms of scale, applications, and
phase of development, allowed us to explore the use of these techniques in distinct circumstances.
Results showed how the overlay mapping approach provides both overview and the possibility to
focus by zooming in on specific developments and phenomena. For example, in the case of HPV
and TPMT testing technologies, we showed how diﬀerent facets and dynamics of the emergence
process can be revealed by moving across the geographical and social spaces from the city-level
to organisation-level units of analysis. The maps also enable the user to compare diﬀerent
technologies and alternatives in terms of strengths and weaknesses at the portfolio level. As in
the case of RNAi, the mapping can reveal cases of emerging technologies initially concentrated
at a few places with major players hosting the sets of relevant capabilities, competences, and
network relationships, and then diﬀusing across a number of actors according to preferential
attachment mechanisms (Leydesdorﬀ and Rafols, 2011). On this ’journey’ of the emerging
technology, changes in the involved domains of science and technology — especially in the case
of RNAi, the diﬀusion of laboratory research tools in other specialties and disciplines — can
also be revealed with the cognitive mapping.
Notwithstanding the delineation issues associated with emerging technologies, the need of
some qualitative background on the studied technology for the interpretation and refinement of
the mapping, the limitations of the data that can be used (mainly publications and patents),
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overlay mapping can function as heuristic that allow confronting the respective theoretical de-
bates with puzzles in the relevant data as well as informing governance by specifying uncer-
tainties in considerable detail. The mapping may also pose additional questions to the analyst
and decision-maker. The produced perspectives on emergence, according to the set of choices
an analyst takes, may timely suggest directions of further investigation as well as feeding into
political discourse about stumbling blocks ahead and possible openings in the landscapes.
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